Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Mol Cancer Ther. 2013 Feb 26;12(5):696–704. doi: 10.1158/1535-7163.MCT-12-0868

Figure 2. PF02341066 inhibits H3122 growth in a dose-dependent manner and it inhibits H460 growth to a lesser extent.

Figure 2

H3122 (2A) and H460 (2B) lung cancer cells were seeded at 3,000/well in 96-well plate and allowed to attach overnight in triplicate. Cells were then exposed to various concentrations of PF02341066. MTS assay was performed after 24 hr, 48 hr and 72 hr. Bar graphs of mean survival fractions (with respective confidence intervals) of each treatment group relative to control are shown. Note: ** denotes p < 0.01 compared to control.